GLENMARK - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.2
| Stock Code | GLENMARK | Market Cap | 55,087 Cr. | Current Price | 1,954 ₹ | High / Low | 2,286 ₹ |
| Stock P/E | 37.1 | Book Value | 848 ₹ | Dividend Yield | 0.13 % | ROCE | 9.72 % |
| ROE | 7.35 % | Face Value | 1.00 ₹ | DMA 50 | 1,977 ₹ | DMA 200 | 1,859 ₹ |
| Chg in FII Hold | -1.53 % | Chg in DII Hold | 1.48 % | PAT Qtr | 426 Cr. | PAT Prev Qtr | 193 Cr. |
| RSI | 46.4 | MACD | -11.4 | Volume | 4,04,304 | Avg Vol 1Wk | 6,47,757 |
| Low price | 1,275 ₹ | High price | 2,286 ₹ | PEG Ratio | 18.6 | Debt to equity | 0.02 |
| 52w Index | 67.1 % | Qtr Profit Var | 3.00 % | EPS | 0.74 ₹ | Industry PE | 29.1 |
📊 Analysis: Glenmark is trading at ₹1,954, slightly below its 50 DMA (₹1,977) but above its 200 DMA (₹1,859), showing mixed technical signals. RSI at 46.4 indicates weak momentum, while MACD at -11.4 suggests bearish undertone. Intraday volume (4.0 lakh) is below the 1-week average (6.4 lakh), limiting strong intraday moves. Valuation is stretched with a P/E of 37.1 compared to industry P/E of 29.1, and EPS of ₹0.74 is relatively weak despite recent PAT growth.
💡 Optimal Buy Price: ₹1,940–1,950 (near support zone).
🎯 Profit-Taking Levels: ₹1,980–2,000 (short-term resistance near 50 DMA).
🛡️ Stop-Loss: ₹1,920 (below support).
⏱️ If Already Holding: Exit intraday if price fails to sustain above ₹1,940 or if MACD continues negative with weakening momentum. Consider booking profits near ₹1,980–2,000 if price action stalls and volume remains subdued.
✅ Positive
- Quarterly PAT growth from ₹193 Cr. to ₹426 Cr. shows strong earnings improvement.
- DII holdings increased by 1.48%, indicating domestic institutional support.
- Trading above 200 DMA provides longer-term support.
- Low debt-to-equity ratio (0.02) ensures financial stability.
⚠️ Limitation
- Weak EPS of ₹0.74 compared to valuation levels.
- High PEG ratio (18.6) signals poor growth alignment with valuation.
- ROCE (9.72%) and ROE (7.35%) are modest compared to peers.
- Intraday volume below average reduces trading opportunities.
📉 Company Negative News
- Decline in FII holdings (-1.53%) indicates reduced foreign investor confidence.
📈 Company Positive News
- Strong quarterly PAT growth highlights operational improvement.
- DII inflows show domestic institutional confidence in the stock.
🏭 Industry
- Industry P/E at 29.1 is lower than Glenmark’s 37.1, suggesting relative overvaluation.
- Pharmaceutical sector demand remains resilient with defensive characteristics.
🔎 Conclusion
Glenmark shows limited intraday potential due to weak momentum and bearish MACD. While fundamentals show recent profit growth, valuation concerns and subdued volume suggest caution. Suitable only for disciplined intraday traders with tight stop-loss and modest profit targets around ₹1,980–2,000.